163 related articles for article (PubMed ID: 37326491)
21. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx.
Takasugi J; Shimamura M; Koda T; Kishikawa T; Hanamoto A; Inohara H; Sato K; Morii E; Motomura M; Sakaguchi M; Nakatsuji Y; Mochizuki H
Intern Med; 2018 Feb; 57(4):587-590. PubMed ID: 29093415
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies.
Pavolucci L; Giannini G; Giannoccaro MP; Foschini MP; Lang B; Avoni P; Tinuper P; Vincent A; Liguori R
Muscle Nerve; 2017 Nov; 56(5):998-1000. PubMed ID: 28006860
[TBL] [Abstract][Full Text] [Related]
23. [Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma].
Shipley E; Krim E; Deminière C; Lagueny A
Rev Neurol (Paris); 2008 Jan; 164(1):72-6. PubMed ID: 18342060
[TBL] [Abstract][Full Text] [Related]
24. Unusual paraneoplastic syndromes in pancreatic cancer: a case report of Lambert-Eaton myasthenic syndrome (LEMS) associated with intraductal papillary mucinous cancer of the pancreas.
Zamparas A; Herzog T; Förster S; Siglienti I; Uhl W; Strotmann J; Höhn P
AME Case Rep; 2023; 7():35. PubMed ID: 37942046
[TBL] [Abstract][Full Text] [Related]
25. Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: a case study.
Lee JH; Baek SK; Han JJ; Kim HJ; Lee YA; Yoo D; Maeng CH
J Chemother; 2023 May; 35(3):275-280. PubMed ID: 35549636
[TBL] [Abstract][Full Text] [Related]
26. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
[TBL] [Abstract][Full Text] [Related]
27. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
28. Unusual paraneoplastic syndromes of breast carcinoma: a combination of cerebellar degeneration and Lambert-Eaton Myasthenic Syndrome.
Romics L; McNamara B; Cronin PA; O'Brien ME; Relihan N; Redmond HP
Ir J Med Sci; 2011 Jun; 180(2):569-71. PubMed ID: 19005633
[TBL] [Abstract][Full Text] [Related]
29. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
30. [Lambert-Eaton myasthenic syndrome].
Motomura M; Fukuda T
Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
[TBL] [Abstract][Full Text] [Related]
31. Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.
Hülsbrink R; Hashemolhosseini S
Clin Neurophysiol; 2014 Dec; 125(12):2328-36. PubMed ID: 25065299
[TBL] [Abstract][Full Text] [Related]
32. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
33. Anti-SOX1 Antibody-Positive Paraneoplastic Syndrome Presenting with Subacute Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome: A Case Report.
Cheng YC; Chang A; Hsu WC
Acta Neurol Taiwan; 2021 Jun; 30(2)():74-77. PubMed ID: 34549392
[TBL] [Abstract][Full Text] [Related]
34. Anti-Hu paraneoplastic syndrome presenting with brainstem-cerebellar symptoms and Lambert-Eaton myasthenic syndrome.
Nagashima T; Mizutani Y; Kawahara H; Maguchi S; Terayama Y; Shinohara T; Orba Y; Chuma T; Mano Y; Itoh T; Sawa H; Sakai K; Motomura M; Nagashima K
Neuropathology; 2003 Sep; 23(3):230-8. PubMed ID: 14570293
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine carcinoma of the larynx with Lambert-Eaton myasthenic syndrome: a rare case report and literature review.
Mesolella M; Allosso S; Buono S; Ricciardiello F; Motta G
J Int Med Res; 2021 May; 49(5):3000605211014784. PubMed ID: 33983073
[TBL] [Abstract][Full Text] [Related]
36. Lambert-Eaton Myasthenic Syndrome.
Kesner VG; Oh SJ; Dimachkie MM; Barohn RJ
Neurol Clin; 2018 May; 36(2):379-394. PubMed ID: 29655456
[TBL] [Abstract][Full Text] [Related]
37. Lambert-Eaton myasthenic syndrome during anesthesia: a report of 37 patients.
Weingarten TN; Araka CN; Mogensen ME; Sorenson JP; Marienau ME; Watson JC; Sprung J
J Clin Anesth; 2014 Dec; 26(8):648-53. PubMed ID: 25468580
[TBL] [Abstract][Full Text] [Related]
38. Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study.
Stege HM; Haist M; Schultheis S; Fleischer MI; Mohr P; Ugurel S; Terheyden P; Thiem A; Kiecker F; Leiter U; Becker JC; Meissner M; Kleeman J; Pföhler C; Hassel J; Grabbe S; Loquai C
Cancer Immunol Immunother; 2021 Nov; 70(11):3313-3322. PubMed ID: 33870464
[TBL] [Abstract][Full Text] [Related]
39. Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
[TBL] [Abstract][Full Text] [Related]
40. [Severe necrotizing myopathy subsequent to Merkel cell carcinoma].
Hocar O; Poszepczynska-Guigné E; Faye O; Wechsler J; Bagot M; Buffard V
Ann Dermatol Venereol; 2011 Feb; 138(2):130-4. PubMed ID: 21333825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
